Reconstitution of endoplasmic reticulum in rapidly dividing cells of early Xenopus embryos.
The cytology of early blastomeres of Xenopus laevis embryos was examined. Particular attention was given to the organization of the nuclear envelope of karyomeres (chromosome vesicles) and the endoplasmic reticulum (ER) at different stages in early cleavage cycles of frog development. Nuclear envelope formation was observed to occur rapidly around individual chromosomes during early anaphase, and karyomeres fused subsequently to yield the final nucleus during telophase. Endoplasmic reticulum in the perinuclear cytoplasm was observed to be vesicular during metaphase and cisternal in form during telophase. Following microinjection of rat liver rough microsomes into early blastomeres, heterologous ER components were identified by electron microscope immunocytochemistry. The foreign ER was observed as large, reconstituted cisternae at stages in the cell cycle when the nuclear envelope was intact. Therefore, transplanted ER maintained the capacity to reconstitute in the cytoplasm of a rapidly dividing cell. In an attempt to better assess ER structure at the metaphase stage of the cell cycle, we next slowed down the division process by treating Xenopus embryos with anti-microtubule agents. Treatment with critical concentrations of colchicine, nocodazole, or vinblastine led to cleavage arrest but not to inhibition of the nuclear cycle. Following such treatment, homologous ER was observed in a vesicular form at all stages of the nuclear cycle. Heterologous ER, however, identified by immunocytochemistry in microinjected cells treated with nocodazole, displayed both vesicular and cisternal forms. We conclude that microinjected ER membranes exhibit cell-cycle-specific behavior, which is different from that of the host cell ER.
Manuel Dominguez
J
J
Département d'Anatomie, Université de Montréal, Québec, Canada.
Paiement
J
J
D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology; D001757:Blastomeres / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D002453:Cell Cycle; D002455:Cell Division; D002467:Cell Nucleus / Q000502:physiology / Q000648:ultrastructure; D002875:Chromosomes / Q000187:drug effects / Q000648:ultrastructure; D003600:Cytosol / Q000502:physiology / Q000648:ultrastructure; D004625:Embryo, Nonmammalian / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D005260:Female; D006801:Humans; D008297:Male; D008845:Microinjections; D008870:Microtubules / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D015739:Nocodazole; D051381:Rats; D013094:Spermatozoa / Q000502:physiology; D014183:Transplantation, Heterologous; D014982:Xenopus laevis
D001562:Benzimidazoles; D015739:Nocodazole